Kevin Harrington - Reader in Biological Cancer Therapies - Institute of Cancer Research | LinkedIn
Professor Kevin Harrington - The Institute of Cancer Research, London
Longtime Fan Uses Ducks Hockey in His Cancer Fight
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
Professor Kevin Harrington - The Institute of Cancer Research, London
Scientific Lecture | Kevin Harrington | FRONTAL
ESMO Immuno-Oncology Congress 2022 What you can expect - YouTube
Clinical results, patient cases and future developments II: Head & neck cancer – Kevin Harrington on Vimeo
T-VEC: what's next for oncolytic virotherapy and immuno-oncology? - Oncology Central
Professor Kevin Harrington, I [IMAGE] | EurekAlert! Science News Releases
ESMO Immuno-Oncology Virtual Congress 2020 - YouTube
Kevin Harrington | Videos & Research | VJOncology
Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer - ecancer
Lapatinib not found to be beneficial in head and neck cancer with high risk of recurrence - ecancer
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile
Professor Kevin Harrington | The Royal Marsden
SAB and I-O AB - T3 Pharma
Kevin Harrington - Reader in Biological Cancer Therapies - Institute of Cancer Research | LinkedIn
Professor Kevin Harrington - YouTube
Potential of immunotherapy in head and neck cancer | VJOncology
Bladder Cancer Survivor Mentors Others with Bladder Cancer | Thrive Fall 2019 | University of Michigan Rogel Cancer Center
Potential of immunotherapy in head and neck cancer | VJOncology
Kevin Harrington - Reader in Biological Cancer Therapies - Institute of Cancer Research | LinkedIn
Loop | Kevin Joseph Harrington
World-first centre for recurrent head & neck cancer - Professor Christopher Nutting Oncology
Scientific Advisory Board – PsiVac
